Professor Mike Gorley From UK Atomic Energy Authority to Join Board of Directors of ASP Isotopes Inc.
19 Octubre 2023 - 7:00AM
ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI", the "Company", "us", "we"
or "our"), an advanced materials company dedicated to the
development of technology and processes designed to produce
isotopes for use in multiple industries, today announced that
Professor Mike Gorley, Chief Technologist at the UK Atomic Energy
Authority is to join the board of directors of the Company.
Professor Gorley is Chief Technologist at the UK
Atomic Energy Authority and a visiting Professor at the University
of Bristol, U.K. He is a well-known expert in fusion technology and
fusion materials. In 2014, Mike was awarded a Ph.D. (DPhil) in
Materials Science from Oxford University, U.K., with a thesis on
ODS steels (specialized alloys for high-performance applications).
Soon after joining the UK Atomic Energy Authority in 2016, Mike
directed the establishment of the Materials Technology group and
supporting materials testing laboratories and led the EUROfusion
Engineering Data and Design Integration group. For the past three
years, Mike has served as a Strategic leader and program area
manager for fusion technology at the UK Atomic Energy
Authority.
Paul Mann, Chairman and CEO of ASP Isotopes Inc.
said, “We are pleased to welcome Professor Gorley to the Board of
Directors of ASP Isotopes. Mike has a deep understanding of
materials used in the nuclear industry. Following the incorporation
of Quantum Leap Energy LLC and its U.K. subsidiary, we anticipate
Mike’s knowledge of the nuclear fuel supply chain will assist
management in navigating the complex regulatory environment.”
Prof. Gorley commented, “The nuclear fuels that
the world will require in the future are very different from those
that have been used historically. Currently, there is no Western
producer of fuels such as HALEU or Lithium-6. Each are critical for
the development of small modular reactors and fusion energy. I look
forward to working with the scientists at ASP Isotopes and Quantum
Leap Energy as they try to solve the current supply chain issues
that are clearly evident.”
Concurrent with Professor Gorley’s appointment,
Sergey Vasnetsov will step down from the Board of Directors, but
will continue to act as a consultant to the Company. Following
these changes to the board of directors, the Company expects to
comply with NASDAQ listing requirements regarding the number and
ratio of independent and non-independent directors.
About ASP Isotopes Inc.
ASP Isotopes Inc. is an advanced materials
company dedicated to developing technology and processes to produce
isotopes in multiple industries. The Company employs proprietary
technology, the Aerodynamic Separation Process (“ASP technology”),
for the production of all isotopes. The Company’s initial focus is
on producing and commercializing highly enriched isotopes for the
healthcare and technology industries. The Company also plans to
enrich isotopes for the nuclear energy sector. The Company has
isotope enrichment facilities in Pretoria, South Africa, dedicated
to the enrichment of isotopes of elements with a low atomic mass
(light isotopes).
There is a growing demand for isotopes such as
Silicon-28, which will enable quantum computing, and
Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and
Nickel-64 for new, emerging healthcare applications, as well as
Chlorine-37, Lithium-6, and Uranium-235 for green energy
applications. The ASP Technology (Aerodynamic Separation Process)
is ideal for enriching low and heavy atomic mass molecules. For
more information, please visit www.aspisotopes.com.
Forward Looking Statements
This press release contains “forward-looking
statements” within the meaning of the safe harbor provisions of the
U.S. Private Securities Litigation Reform Act of 1995, including,
without limitation, statements relating to the expected closing of
the private placement, the adequacy of resources required to
achieve first revenues and the acceleration of high
return-on-investment, growth projects. Forward-looking statements
are neither historical facts nor assurances of future performance.
Instead, they are based only on our current beliefs, expectations,
and assumptions regarding the future of our business, future plans
and strategies, projections, anticipated events and trends, the
economy, and other future conditions. Forward-looking statements
can be identified by words such as “believes,” “plans,”
“anticipates,” “expects,” “estimates,” “projects,” “will,” “may,”
“might,” and words of a similar nature. Examples of forward-looking
statements include, among others but are not limited to, statements
we make regarding expected operating results, such as future
revenues and prospects from the potential commercialization of
isotopes, future performance under contracts, and our strategies
for product development, engaging with potential customers, market
position, and financial results. Because forward-looking statements
relate to the future, they are subject to inherent uncertainties,
risks, and changes in circumstances that are difficult to predict,
many of which are outside our control. Our actual results,
financial condition, and events may differ materially from those
indicated in the forward-looking statements based upon a number of
factors. Forward-looking statements are not a guarantee of future
performance or developments. You are strongly cautioned that
reliance on any forward-looking statements involves known and
unknown risks and uncertainties. Therefore, you should not rely on
any of these forward-looking statements. There are many important
factors that could cause our actual results and financial condition
to differ materially from those indicated in the forward-looking
statements, including: our reliance on the efforts of third
parties; our ability to complete the construction and commissioning
of our enrichment plants or to commercialize isotopes using the ASP
technology or the Quantum Enrichment Process; our ability to obtain
regulatory approvals for the production and distribution of
isotopes; the financial terms of any current and future commercial
arrangements; our ability to complete certain transactions and
realize anticipated benefits from acquisitions; contracts,
dependence on our Intellectual Property (IP) rights, certain IP
rights of third parties; and the competitive nature of our
industry. Any forward-looking statement made by us in this press
release is based only on information currently available to us and
speaks only as of the date on which it is made. We undertake no
obligation to publicly update any forward-looking statement,
whether as a result of new information, future developments or
otherwise. This press release includes market and industry data and
forecasts that we obtained from internal research, publicly
available information and industry publications and surveys.
Industry publications and surveys generally state that the
information contained therein has been obtained from sources
believed to be reliable. Unless otherwise noted, statements as to
our potential market position relative to other companies are
approximated and based on third-party data and internal analysis
and estimates as of the date of this press release. We have not
independently verified this information, and it could prove
inaccurate. Industry and market data could be wrong because of the
method by which sources obtained their data and because information
cannot always be verified with certainty due to the limits on the
availability and reliability of raw data, the voluntary nature of
the data-gathering process and other limitations and uncertainties.
In addition, we do not know all of the assumptions regarding
general economic conditions or growth that were used in preparing
the information and forecasts from sources cited herein. No
information in this press release should be interpreted as an
indication of future success, revenues, results of operation, or
stock price. All forward-looking statements herein are qualified by
reference to the cautionary statements set forth herein and should
not be relied upon.
Contacts
Jason Assad– Investor relationsEmail:
Jassad@aspisotopes.comTelephone: 561-709-3043
ASP Isotopes (NASDAQ:ASPI)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
ASP Isotopes (NASDAQ:ASPI)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024